NewsRx

Search our medical news database

Breast Cancer (Therapy)

Tamoxifen Regime Best Hope To Beat Breast Cancer

Published in Women's Health Weekly, November 18th, 1996

The lifesaving benefit of taking tamoxifen to treat early breast cancer lasts for at least a decade, but only if the drug is used for five years and no longer, two studies show.

The studies, published in the November 6, 1996, issue of the Journal of the National Cancer Institute, found that women who took tamoxifen for five years after early breast cancer surgery had about an 18 percent better chance of surviving without relapse than patients who did not take the drug.

One study showed that taking the drug for longer than five years conferred no survival advantage and could risk other disorders.

Experts praised the studies as...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook